Literature DB >> 19429025

Partial regulation of serotonin transporter function by gamma-synuclein.

Christophe Wersinger1, Anita Sidhu.   

Abstract

Human alpha-synuclein (alpha-Syn) is instrumental in maintaining homeostasis of monoamine neurotransmitters in brain, through its trafficking, and regulation of the cell surface expression and, thereby, activity of dopamine, serotonin and norepinephrine transporters. Here we have investigated whether other members of the synuclein family of proteins, gamma-synuclein (gamma-Syn) and beta-synuclein (beta-Syn) can similarly modulate the serotonin transporter (SERT). In Ltk(-) cells co-transfected with SERT and gamma-Syn, gamma-Syn reduced [(3)H]5-HT uptake, in a manner dependent on its expression levels. The decrease in SERT activity was via decreased V(max) of the transporter, without change in K(m), compared to cells expressing only SERT. By contrast, beta-Syn co-expression failed to alter SERT uptake activity, and neither the V(max) nor the K(m) was changed in the presence of beta-Syn. gamma-Syn modulation of SERT was only partial, with a maximal approximately 27% decrease in SERT activity seen even at high expression levels of gamma-Syn. By contrast, alpha-Syn attenuated SERT activity by approximately 65% at identical expression levels as gamma-Syn. Co-immunoprecipitation studies showed the presence of heteromeric protein:protein complexes between gamma-Syn or alpha-Syn and SERT, while beta-Syn failed to physically interact with SERT. Both alpha-Syn and gamma-Syn colocalized with SERT in rat primary raphae nuclei neurons. These studies document a novel physiological role for gamma-Syn in regulating 5-HT synaptic availability and homeostasis, and may be of relevance in depression and mood disorders, where SERT function is dysregulated.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19429025      PMCID: PMC2825691          DOI: 10.1016/j.neulet.2009.02.033

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  22 in total

Review 1.  Plasma membrane monoamine transporters: structure, regulation and function.

Authors:  Gonzalo E Torres; Raul R Gainetdinov; Marc G Caron
Journal:  Nat Rev Neurosci       Date:  2003-01       Impact factor: 34.870

Review 2.  Genetic perspectives on the serotonin transporter.

Authors:  D L Murphy; Q Li; S Engel; C Wichems; A Andrews; K P Lesch; G Uhl
Journal:  Brain Res Bull       Date:  2001-11-15       Impact factor: 4.077

3.  Desipramine modulation of alpha-, gamma-synuclein, and the norepinephrine transporter in an animal model of depression.

Authors:  Alexis M Jeannotte; John G McCarthy; Eva E Redei; Anita Sidhu
Journal:  Neuropsychopharmacology       Date:  2008-09-17       Impact factor: 7.853

4.  Attenuation of dopamine transporter activity by alpha-synuclein.

Authors:  Christophe Wersinger; Anita Sidhu
Journal:  Neurosci Lett       Date:  2003-04-17       Impact factor: 3.046

Review 5.  Origin and functional role of the extracellular serotonin in the midbrain raphe nuclei.

Authors:  Albert Adell; Pau Celada; M Teresa Abellán; Francesc Artigas
Journal:  Brain Res Brain Res Rev       Date:  2002-09

6.  Mutations in the lipid-binding domain of alpha-synuclein confer overlapping, yet distinct, functional properties in the regulation of dopamine transporter activity.

Authors:  Christophe Wersinger; Delphine Prou; Philippe Vernier; Hyman B Niznik; Anita Sidhu
Journal:  Mol Cell Neurosci       Date:  2003-09       Impact factor: 4.314

7.  Trypsin disrupts the trafficking of the human dopamine transporter by alpha-synuclein and its A30P mutant.

Authors:  Christophe Wersinger; Philippe Vernier; Anita Sidhu
Journal:  Biochemistry       Date:  2004-02-10       Impact factor: 3.162

8.  Comparative analyses of alpha-synuclein expression levels in rat brain tissues and transfected cells.

Authors:  Christophe Wersinger; Melanie Banta; Anita Sidhu
Journal:  Neurosci Lett       Date:  2004-03-25       Impact factor: 3.046

Review 9.  Monoamine transporters and psychostimulant drugs.

Authors:  Richard B Rothman; Michael H Baumann
Journal:  Eur J Pharmacol       Date:  2003-10-31       Impact factor: 4.432

10.  Modulation of dopamine transporter function by alpha-synuclein is altered by impairment of cell adhesion and by induction of oxidative stress.

Authors:  Christophe Wersinger; Delphine Prou; Philippe Vernier; Anita Sidhu
Journal:  FASEB J       Date:  2003-09-04       Impact factor: 5.191

View more
  8 in total

Review 1.  Synuclein modulation of monoamine transporters.

Authors:  Adam W Oaks; Anita Sidhu
Journal:  FEBS Lett       Date:  2011-03-23       Impact factor: 4.124

Review 2.  Heteromeric Solute Carriers: Function, Structure, Pathology and Pharmacology.

Authors:  Stephen J Fairweather; Nishank Shah; Stefan Brӧer
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

3.  3,4-methylenedioxymethamphetamine induces gene expression changes in rats related to serotonergic and dopaminergic systems, but not to neurotoxicity.

Authors:  Elisabet Cuyas; Patricia Robledo; Nieves Pizarro; Magí Farré; Elena Puerta; Norberto Aguirre; Rafael de la Torre
Journal:  Neurotox Res       Date:  2013-08-15       Impact factor: 3.911

4.  Altered gene expression profiles in the hippocampus and prefrontal cortex of type 2 diabetic rats.

Authors:  Omar Abdul-Rahman; Maria Sasvari-Szekely; Agota Ver; Klara Rosta; Bernadett K Szasz; Eva Kereszturi; Gergely Keszler
Journal:  BMC Genomics       Date:  2012-02-27       Impact factor: 3.969

5.  Differential involvement of the gamma-synuclein in cognitive abilities on the model of knockout mice.

Authors:  Viktor S Kokhan; Gennadiy I Van'kin; Sergey O Bachurin; Inna Yu Shamakina
Journal:  BMC Neurosci       Date:  2013-05-14       Impact factor: 3.288

6.  Synucleins antagonize endoplasmic reticulum function to modulate dopamine transporter trafficking.

Authors:  Adam W Oaks; Nicholas Marsh-Armstrong; Jessica M Jones; Joel J Credle; Anita Sidhu
Journal:  PLoS One       Date:  2013-08-13       Impact factor: 3.240

7.  N-ethylmaleimide-sensitive factor interacts with the serotonin transporter and modulates its trafficking: implications for pathophysiology in autism.

Authors:  Keiko Iwata; Hideo Matsuzaki; Taro Tachibana; Koji Ohno; Saori Yoshimura; Hironori Takamura; Kohei Yamada; Shinsuke Matsuzaki; Kazuhiko Nakamura; Kenji J Tsuchiya; Kaori Matsumoto; Masatsugu Tsujii; Toshirou Sugiyama; Taiichi Katayama; Norio Mori
Journal:  Mol Autism       Date:  2014-05-10       Impact factor: 7.509

8.  New α- and γ-synuclein immunopathological lesions in human brain.

Authors:  Irina Surgucheva; Kathy L Newell; Jeffrey Burns; Andrei Surguchov
Journal:  Acta Neuropathol Commun       Date:  2014-09-11       Impact factor: 7.801

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.